New trial aims to solve the mystery of cancers with unknown origins

NCT ID NCT07366008

First seen Feb 01, 2026 · Last updated May 11, 2026 · Updated 14 times

Summary

This study aims to improve diagnosis and treatment for people with Cancer of Unknown Primary (CUP), where the original tumor site cannot be found. Researchers will use advanced molecular profiling of tumor tissue and blood samples to identify the likely origin and guide personalized therapy. The trial will enroll 350 participants and compare outcomes to historical data to see if this approach improves survival.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER OF UNKNOWN PRIMARY SITE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Akershus University Hospital

    Oslo, Norway

    Contact Email: •••••@•••••

  • Haukeland University Hospital

    Bergen, 5021, Norway

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Oslo University Hospital

    Oslo, Norway

    Contact Email: •••••@•••••

  • St Olavs Hospital

    Trondheim, Norway

    Contact Email: •••••@•••••

  • Stavanger University Hospital

    Stavanger, Norway

    Contact Email: •••••@•••••

  • University Hospital of North-Norway

    Tromsø, Norway

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.